Salisbury Foundation Trust

FOI_9387

Internal Reference Number: FOI_9387

Date Request Received: 05/05/2026 00:00:00

Date Request Replied To: 21/05/2026 00:00:00

This response was sent via: By Email

Request Summary: Biologics Rheumatology

Request Category: Researcher



 
Question Number 1:
Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:

• Abatacept [Orencia]

• Adalimumab [Humira]

• Adalimumab Biosimilars

• Apremilast [Otezla]

• Apremilast [Generic]

• Baricitinib [Olumiant]

• Bimekizumab [Bimzelx]

• Certolizumab [Cimzia]

• Etanercept [Enbrel]

• Etanercept Biosimilars

• Filgotinib [Jyseleca]

• Golimumab [Simponi]

• Golimumab Biosimilar

• Guselkumab [Tremfya]

• Infliximab [Remicade]

• Infliximab Biosimilars

• Ixekizumab [Taltz]

• Risankizumab [Skyrizi]

• Rituximab [MabThera]

• Rituximab Biosimilars

• Sarilumab [Kevzara]

• Secukinumab [Cosentyx]

• Tocilizumab [Ro Actemra]

• Tocilizumab Biosimilars

• Tofacitinib [Xeljanz]

• Upadacitinib [Rinvoq]

• Ustekinumab [Stelara]

• Ustekinumab Biosimilar
 
Answer To Question 1:
Please find our response to all questions in the spreadsheet attached.

To accompany this answer to question 1 please also see the documents listed below:

 13719 - FOI_9387 - Biologics Rheumatology - FOR ISSUE v2.xlsx
 
Question Number 2:
Could you please provide the numbers of patients treated for Psoriatic Arthritis (PsA) ONLY in the last 3 months with the following drugs:

• Abatacept [Orencia]

• Adalimumab [Humira]

• Adalimumab Biosimilars

• Apremilast [Otezla]

• Apremilast [Generic]

• Bimekizumab [Bimzelx]

• Certolizumab [Cimzia]

• Etanercept [Enbrel]

• Etanercept Biosimilars

• Golimumab [Simponi]

• Golimumab Biosimilar

• Guselkumab [Tremfya]

• Infliximab [Remicade]

• Infliximab Biosimilars

• Ixekizumab [Taltz]

• Risankizumab [Skyrizi]

• Secukinumab [Cosentyx]

• Tofacitinib [Xeljanz]

• Upadacitinib [Rinvoq]

• Ustekinumab [Stelara]

• Ustekinumab Biosimilar
 
Answer To Question 2:
Please see response to all questions in the spreadsheet attached. Q2 on tab 2
Please see Attachments:
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2026 Salisbury NHS Foundation Trust
Trust Values